SNCA and Parkinson disease: Among them, the levels of DJ-1 and α-synuclein in human cerebrospinal fluid and blood between PD patients and non-PD controls are the most frequently tested biomarkers in previous studies; however, the results are conflicting [9], [10], [11], [12], [13].